Medium materiality6/10
Canaccord Reiterates Buy Rating on Bioventus Inc (BVS)
Why it may matterVerify against the original reporting
Reiteration of Buy suggests continued upside.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity reiterates Buy on BVS; target $15; current price $8.60.
- Target: $15
- Price: $8.60
- Firm: Canaccord Genuity
Key facts
- 01
Target: $15
- 02
Posted price: $8.6
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Caitlin Cronin
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.